Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
12/2005
12/22/2005WO2005086735A3 Novel bicyclic compounds as modulators of androgen receptor function and method
12/22/2005WO2005053610A3 Diamine and iminodiacetic acid hydroxamic acid derivatives
12/22/2005US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR
12/22/2005US20050282898 Methods for the synthesis of milnacipran and congeners thereof
12/22/2005US20050282882 Diamines as modulators of chemokine receptor activity
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282866 2,3-Diphenyl-1H-indole-5-carboxylic acid; I kappa B kinase inhibitor; decrease activation of nuclear factor (NF) kappa B; antiinflammatory agent: arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, carcinomateous disorders or atherosclerosis
12/22/2005US20050282864 Indole derivatives as H3 inverse agonists
12/22/2005US20050282863 Novel-N substituted dihydrobenzothiepino, dihydrobenzoxepino and tetrahydro benzocyclohepta indoles as selective estrogen receptor modulators
12/22/2005US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/22/2005US20050282822 Therapeutic agents
12/22/2005US20050282821 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
12/22/2005US20050282814 Vasculostatic agents and methods of use thereof
12/22/2005US20050282810 Oxindole derivatives
12/22/2005US20050282787 Synthesis of tetracyclines and analogues thereof
12/22/2005US20050281741 Using cyanine dyes; in situ target tumor cells
12/22/2005US20050280960 Magnetic random access memory array with coupled soft adjacent magnetic layer
12/22/2005CA2569887A1 Pyrrolopyridine derivatives
12/22/2005CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005CA2567835A1 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/22/2005CA2567342A1 Aza-bicyclo[3.1.0]hex-1-yl derivatives active as nk1 antagonists
12/22/2005CA2564642A1 Lxr receptor modulators
12/21/2005EP1607392A1 Blue light-emitting compound, method for producing same and light-emitting device utilizing same
12/21/2005EP1607091A1 Antihepatitis c virus agent and anti-hiv agent
12/21/2005EP1606351A2 Cyanine dye labelling reagents with meso-substitution
12/21/2005EP1606256A2 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses
12/21/2005EP1606254A1 2,4,6-phenyl substituted cyclic ketoenols
12/21/2005EP1605896A2 7-amino- isoindolyl compounds amd their pharmaceutical uses
12/21/2005EP1432701B1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
12/21/2005EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
12/21/2005EP1125924B1 Intermediate for the synthesis of amlodipine, preparation process and corresponding utilization
12/21/2005CN1711082A Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them
12/21/2005CN1709872A Imine biatomic acid intermediate and its preparing method
12/21/2005CN1709871A S-(-)-indolyl-2-carboxylic acid synthesizing method
12/21/2005CN1232518C Bi-heterocyclic compounds with antitumour and chemosensitising activity
12/21/2005CN1232513C 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it
12/21/2005CN1232507C Growth hormone secretagogues
12/20/2005US6977311 enantiomerically pure; converting pyroglutamic acid, salt or ester to a 4-enamine derivative; hydrolysis to a 4-hydroxymethylidene derivative; reduction; and decyclization using a strong base
12/20/2005US6977305 Modified carbocyanine dyes and their conjugates
12/20/2005US6977304 Catalyzing the cyclization reaction in liquid in presence of one or more Lewis acids mixture; a simple, reproducible method with increased safety, efficiency; making 1,2,3,4-tetrahydrocarbazol-4-one
12/20/2005US6977298 Tricyclic inhibitors of poly(ADP-ribose) polymerases
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/20/2005CA2176962C N-substituted azabicycloheptane derivatives, their preparation and use
12/15/2005WO2005119794A1 Materials for photoelectric conversion devices and photoelectric conversion devices
12/15/2005WO2005118564A2 Methods for the synthesis of milnacipran and congeners thereof
12/15/2005WO2005118539A1 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor
12/15/2005WO2005118538A2 Arylsulfonamides and uses as hydroxysteroid dehydrogenase
12/15/2005WO2005118537A2 Arylpiperazine derivatives as adrenergic receptor antagonists
12/15/2005WO2005117904A2 Phosphonate analogs of hiv integrase inhibitor compounds
12/15/2005WO2005117865A1 Naphthaline derivatives useful as histamine-3-receptor ligands
12/15/2005WO2005074598A3 Nitroxyl progenitor compounds and methods of use
12/15/2005US20050277690 Small molecules for treatment of hypercholesterolemia and related diseases
12/15/2005US20050277689 carvedilol mandelate or carvedilol sulfate salt for treating hypertension, congestive heart failure or angina cardiovascular disorders
12/15/2005US20050277685 peroxisome proliferator activated receptor agonist such as (2R)-2-(3-{[3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]methyl}phenoxy)butanoic acid, used for treatment and control of metabilic disorders
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277631 Vanilloid receptor ligands and their use in treatments
12/15/2005CA2778894A1 Compounds for measuring nitroreductase enzyme activity
12/15/2005CA2569238A1 Monoamine reuptake inhibitor
12/15/2005CA2562713A1 Phosphonate analogs of hiv integrase inhibitor compounds
12/15/2005CA2561858A1 Arylsulfonamides and uses related thereto
12/14/2005EP1603914A1 Compounds having activity at 5ht2c receptor and uses thereof
12/14/2005EP1603913A1 Solvent-free process for the preparation of diketopyrrolopyrrole derivatives
12/14/2005EP1603858A2 Kcnq channel modulating compounds and their pharmaceutical use
12/14/2005EP1603562A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
12/14/2005EP1603558A1 Process for preparation of perindopril and salts thereof
12/14/2005EP1492766A4 Improved cc-1065 analog synthesis
12/14/2005EP1438290B1 Cyclohept b!indole derivatives as spla2 inhibitors
12/14/2005EP1261583B1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/14/2005EP1224165B1 Novel compounds
12/14/2005EP1119562B1 2,3-dihydro-1h-isoindole derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
12/14/2005EP1066258B1 Aryl phenyl substituted cyclic ketoenols
12/14/2005CN1708560A Beta-isoindigo coloring agent
12/14/2005CN1708476A Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
12/14/2005CN1706830A Prepn process of N-methyl-4-(dimethyl phenoxy) phthalimide
12/14/2005CN1706829A Double indolyl derivative synthesizing process
12/14/2005CN1706828A Metal ion double salt with vitamin F as active component and its orally taken solid prepn and freeze dried injection
12/14/2005CN1706827A 5-hydroxyindole-3-carboxylate derivative and its use
12/14/2005CN1706826A Antioxidation compound for suppressing activity of enzyme oxide
12/14/2005CN1231487C Metallocenes and catalysts for olefin-polymerisation
12/14/2005CN1231465C Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
12/14/2005CN1231464C Novel 3-substituted urea derivatives and medicinal use thereof
12/14/2005CN1231461C Bicyclo [2.2.1] heptanes and related compounds
12/14/2005CN1231458C Novel aryloxy-alkyl-dialkylamines compound
12/14/2005CN1231439C Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand
12/14/2005CN1231433C Transfer hydrogenation process
12/13/2005US6974873 Preferential compound for use as diagnostic tool
12/13/2005US6974836 Diamines as modulators of chemokine receptor activity
12/13/2005US6974831 sPLA2 inhibitors
12/13/2005CA2363658C Improved process for the preparation of ramipril
12/08/2005WO2005117242A1 Method and installation means for installing an electrical machine
12/08/2005WO2005116027A2 Indazole and indolone derivatives and their use as pharmaceuticals
12/08/2005WO2005115982A1 Process for producing a dipeptidyl peptidase iv inhibitor
12/08/2005WO2005115981A2 A process for the preparation of 1-(9h-carbazol-4-yloxy)-3-2-(-methoxyphenoxy)-ethyl amino-propan-2-ol
12/08/2005WO2005085196A3 Inhibitors of dna methylation in tumor cells
12/08/2005WO2005077932A3 Chemokine receptor antagonists
12/08/2005WO2005040111A3 Combinatorial library of 3-aryl-1h-indole-2-carboxylic acids
12/08/2005WO2004058911A3 Organic electroluminescent element
12/08/2005US20050272939 Crystals of free (2R, 4R)-monatin and use thereof
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272823 improved selectivity and pharmacokinetic properties; 6-Fluoro-1-[(1 H-indazol-4-yl)amino]-4,4-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalene-2,5-diol; cyclization of imines
1 ... 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 ... 458